CONMED (CNMD) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 6.59 | 4.19 | 131.6 | 0.00 | 5.31 | 3.95 | |||
Changes by years, y/y, % | +11% | -36% | +3 039% | -100% | -2.9% |
CONMED. Debt/EBITDA
CONMED. Debt/EBITDA, changes, %
CONMED (CNMD) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 0.00 | 7.36 | 5.51 | 4.85 | 3.95 | 3.95 | ||
Changes by years, y/y, % | -100% | -130% | -127% | -70% | -72% | |||
Changes by quarters, q/q, % | -100% | -25% | -12% | -19% |